Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05050084
Title Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors NRG Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.